Literature DB >> 8343666

Josamycin-induced pedal oedema.

X Bosch1, E Pedrol, X Casado, A Urbano-Marquez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8343666      PMCID： PMC1678472          DOI： 10.1136/bmj.307.6895.26-a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes.

Authors:  E L Westerman; T W Williams; N Moreland
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

2.  [Treatment of atypical pneumonia with josamycin].

Authors:  J Mensa; A Trilla; I Tarrero; J Vidal; R Estruch; J A Martínez; E Soriano; A Agustí-Vidal
Journal:  Med Clin (Barc)       Date:  1989-03-04       Impact factor: 1.725

3.  Comparison of josamycin and erythromycin in the therapy of Mycoplasma pneumoniae pneumonia.

Authors:  R P Wenzel; J O Hendley; W K Dodd; J M Gwaltney
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

4.  Clinical multicentre trial with josamycin propionate in paediatric patients.

Authors:  G Privitera; S Bonino; S Del Mastro
Journal:  Int J Clin Pharmacol Res       Date:  1984

5.  Comparison of the side effects and gastrointestinal motility observed after administration of erythromycin and josamycin to dogs.

Authors:  X Y Qin; M A Pilot; H H Thompson; J P Maskell
Journal:  J Antimicrob Chemother       Date:  1986-12       Impact factor: 5.790

6.  Comparative pharmacology of josamycin and erythromycin stearate.

Authors:  L J Strausbaugh; W K Bolton; J A Dilworth; R L Guerrant; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191
  6 in total
  1 in total

Review 1.  Macrolide antibiotics.

Authors:  R C Gordon
Journal:  Indian J Pediatr       Date:  1998 Jan-Feb       Impact factor: 1.967
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.